These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18641325)

  • 1. Expression of macrophage migration inhibitory factor by neuroblastoma leads to the inhibition of antitumor T cell reactivity in vivo.
    Zhou Q; Yan X; Gershan J; Orentas RJ; Johnson BD
    J Immunol; 2008 Aug; 181(3):1877-86. PubMed ID: 18641325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annexin-V promotes anti-tumor immunity and inhibits neuroblastoma growth in vivo.
    Yan X; Doffek K; Yin C; Krein M; Phillips M; Sugg SL; Johnson B; Shilyansky J
    Cancer Immunol Immunother; 2012 Nov; 61(11):1917-27. PubMed ID: 22476407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of tumor growth and metastasis in vitro and in vivo by targeting macrophage migration inhibitory factor in human neuroblastoma.
    Ren Y; Chan HM; Fan J; Xie Y; Chen YX; Li W; Jiang GP; Liu Q; Meinhardt A; Tam PK
    Oncogene; 2006 Jun; 25(25):3501-8. PubMed ID: 16449971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-derived macrophage migration inhibitory factor (MIF) inhibits T lymphocyte activation.
    Yan X; Orentas RJ; Johnson BD
    Cytokine; 2006 Feb; 33(4):188-98. PubMed ID: 16522371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of YB-1 as a new immunological target in neuroblastoma by vaccination in the context of regulatory T cell blockade.
    Zheng J; Jing W; Orentas RJ
    Acta Biochim Biophys Sin (Shanghai); 2009 Dec; 41(12):980-90. PubMed ID: 20011972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YB-1 immunization combined with regulatory T-cell depletion induces specific T-cell responses that protect against neuroblastoma in the early stage.
    Zheng J; Liu P; Yang X
    Acta Biochim Biophys Sin (Shanghai); 2012 Dec; 44(12):1006-14. PubMed ID: 23169344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulating mammary tumor growth, metastasis and immunosuppression by siRNA-induced MIF reduction in tumor microenvironment.
    Zhang M; Yan L; Kim JA
    Cancer Gene Ther; 2015 Oct; 22(10):463-74. PubMed ID: 26403072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MIF/CXCR4 signaling axis contributes to survival, invasion, and drug resistance of metastatic neuroblastoma cells in the bone marrow microenvironment.
    Garcia-Gerique L; García M; Garrido-Garcia A; Gómez-González S; Torrebadell M; Prada E; Pascual-Pasto G; Muñoz O; Perez-Jaume S; Lemos I; Salvador N; Vila-Ubach M; Doncel-Requena A; Suñol M; Carcaboso AM; Mora J; Lavarino C
    BMC Cancer; 2022 Jun; 22(1):669. PubMed ID: 35715791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage Migration Inhibitory Factor protects cancer cells from immunogenic cell death and impairs anti-tumor immune responses.
    Balogh KN; Templeton DJ; Cross JV
    PLoS One; 2018; 13(6):e0197702. PubMed ID: 29864117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of macrophage migration inhibitory factor contributes to induced N-Myc expression by the activation of ERK signaling pathway and increased expression of interleukin-8 and VEGF in neuroblastoma.
    Ren Y; Chan HM; Li Z; Lin C; Nicholls J; Chen CF; Lee PY; Lui V; Bacher M; Tam PK
    Oncogene; 2004 May; 23(23):4146-54. PubMed ID: 15064733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the CTL response by macrophage migration inhibitory factor.
    Abe R; Peng T; Sailors J; Bucala R; Metz CN
    J Immunol; 2001 Jan; 166(2):747-53. PubMed ID: 11145646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage migration inhibitory factor promotes tumor invasion and metastasis via the Rho-dependent pathway.
    Sun B; Nishihira J; Yoshiki T; Kondo M; Sato Y; Sasaki F; Todo S
    Clin Cancer Res; 2005 Feb; 11(3):1050-8. PubMed ID: 15709171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage Migration Inhibitory Factor Promotes the Interaction between the Tumor, Macrophages, and T Cells to Regulate the Progression of Chemically Induced Colitis-Associated Colorectal Cancer.
    Pacheco-Fernández T; Juárez-Avelar I; Illescas O; Terrazas LI; Hernández-Pando R; Pérez-Plasencia C; Gutiérrez-Cirlos EB; Ávila-Moreno F; Chirino YI; Reyes JL; Maldonado V; Rodriguez-Sosa M
    Mediators Inflamm; 2019; 2019():2056085. PubMed ID: 31360118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage migration inhibitory factor as a potential prognostic factor in gastric cancer.
    He LJ; Xie D; Hu PJ; Liao YJ; Deng HX; Kung HF; Zhu SL
    World J Gastroenterol; 2015 Sep; 21(34):9916-26. PubMed ID: 26379396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning and functional characterization of the avian macrophage migration inhibitory factor (MIF).
    Kim S; Miska KB; Jenkins MC; Fetterer RH; Cox CM; Stuard LH; Dalloul RA
    Dev Comp Immunol; 2010 Sep; 34(9):1021-32. PubMed ID: 20470818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage Migration Inhibitory Factor (MIF): A Glucocorticoid Counter-Regulator within the Immune System.
    Calandra T; Bucala R
    Crit Rev Immunol; 2017; 37(2-6):359-370. PubMed ID: 29773026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of macrophage migration inhibitory factor by human and murine neuroblastoma.
    Bin Q; Johnson BD; Schauer DW; Casper JT; Orentas RJ
    Tumour Biol; 2002; 23(3):123-9. PubMed ID: 12218292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage migration inhibitory factor (MIF) expression in human malignant gliomas contributes to immune escape and tumour progression.
    Mittelbronn M; Platten M; Zeiner P; Dombrowski Y; Frank B; Zachskorn C; Harter PN; Weller M; Wischhusen J
    Acta Neuropathol; 2011 Sep; 122(3):353-65. PubMed ID: 21773885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmania-encoded orthologs of macrophage migration inhibitory factor regulate host immunity to promote parasite persistence.
    Holowka T; Castilho TM; Garcia AB; Sun T; McMahon-Pratt D; Bucala R
    FASEB J; 2016 Jun; 30(6):2249-65. PubMed ID: 26956417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective immunization against neuroblastoma using double-transduced tumor cells secreting GM-CSF and interferon-gamma.
    Bausero MA; Panoskaltsis-Mortari A; Blazar BR; Katsanis E
    J Immunother Emphasis Tumor Immunol; 1996 Mar; 19(2):113-24. PubMed ID: 8732694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.